Reduced-toxicity conditioning for allogeneic hematopoietic cell transplantation in elderly or comorbid patients with AML using fludarabine, BCNU and melphalan: disease stage at transplant determines outcome.

Item Type:	Letter
Title:	Reduced-toxicity conditioning for allogeneic hematopoietic cell transplantation in elderly or comorbid patients with AML using fludarabine, BCNU and melphalan: disease stage at transplant determines outcome.
Creators Name:	Wais, V. and Kündgen, L. and Bohl, S.R. and von Harsdorf, S. and Schlenk, R.F. and Döhner, K. and Teleanu, V. and Bullinger, L. and Nguyen, T.M. and Drognitz, K. and Moulin, J.C. and Binnenhei, M. and Bentz, M. and Döhner, H. and Bunjes, D. and Kuchenbauer, F. and Ringhoffer, M.
Keywords:	Acute Myeloid Leukaemia, Chemotherapy, Risk Factors, Stem-Cell Therapies
Source:	Bone marrow transplantation
ISSN:	1476-5365
Publisher:	Springer Nature
Volume:	53
Number:	1
Page Range:	94-96
Date:	January 2018
Official Publication:	https://doi.org/10.1038/bmt.2017.211
PubMed:	View item in PubMed

Repository Staff Only: item control page